NEW YORK (GenomeWeb) – Cancer Genetics said today that it has signed a collaboration agreement to aid precision therapeutics firm Lantern Pharma in biomarker discovery, clinical trials, and genomics projects for its lead drug candidates.
NEW YORK (GenomeWeb) – Cancer Genetics said today that it has signed a collaboration agreement to aid precision therapeutics firm Lantern Pharma in biomarker discovery, clinical trials, and genomics projects for its lead drug candidates.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.